Global Patent Index - EP 1496931 A1

EP 1496931 A1 20050119 - METHODS FOR TREATING AN AUTOIMMUNE DISEASE USING A SOLUBLE CTLA4 MOLECULE AND A DMARD OR NSAID

Title (en)

METHODS FOR TREATING AN AUTOIMMUNE DISEASE USING A SOLUBLE CTLA4 MOLECULE AND A DMARD OR NSAID

Title (de)

VERFAHREN ZUR BEHANDLUNG EINER AUTOIMMUNKRANKHEIT MIT EINEM LÖSLICHEN CTLA4-MOLEKÜL UND EINEM DMARD ODER NSAID

Title (fr)

METHODES DE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE AU MOYEN D'UNE MOLECULE CTLA4 SOLUBLE ET D'UN ARMM OU D'UN AINS

Publication

EP 1496931 A1 20050119 (EN)

Application

EP 03747047 A 20030418

Priority

  • US 0312356 W 20030418
  • US 37385202 P 20020419
  • US 40724602 P 20020830

Abstract (en)

[origin: WO03088991A1] The present invention relates to compositions and methods for treating immune system diseases such as rheumatic disease, by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands, alone, or in conjunction with other agents including Disease Modifying Anti-Rheumatic Drugs (DMARDs).

IPC 1-7

A61K 38/16; C07K 14/705

IPC 8 full level

A61K 38/17 (2006.01); A61K 38/39 (2006.01)

CPC (source: EP)

A61K 38/1774 (2013.01); A61K 38/1793 (2013.01)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 03088991 A1 20031030; WO 03088991 A9 20040205; AU 2003243152 A1 20031103; CA 2482042 A1 20031030; EP 1496931 A1 20050119; EP 1496931 A4 20090701

DOCDB simple family (application)

US 0312356 W 20030418; AU 2003243152 A 20030418; CA 2482042 A 20030418; EP 03747047 A 20030418